CNBX PHARMACEUTICALS INC. (CNBX) Total liabilities 2016–2025
CNBX PHARMACEUTICALS INC. (CNBX) total liabilities at each fiscal year-end, per SEC filings.
$2.5MFY2025 · since FY2016: $491,164 → $2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.5M | +0.1% |
| FY2024 | $2.5M | -0.2% |
| FY2023 | $2.5M | +406.4% |
| FY2022 | -$821,145 | -164.5% |
| FY2021 | $1.3M | +179.9% |
| FY2020 | $454,787 | +3.6% |
| FY2019 | $438,874 | -18.6% |
| FY2018 | $539,382 | -91.8% |
| FY2017 | $6.6M | +1238.9% |
| FY2016 | $491,164 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice